![Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial - The Lancet Infectious Diseases Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/91dbf75b-2288-4086-9df9-adddee7ae55e/gr1_lrg.jpg)
Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial - The Lancet Infectious Diseases
Hepatitis Australia - Sadly, there is no vaccine for hepatitis C. However, there are preventive vaccines available for hepatitis B and hepatitis A. Hep C can be cured with new treatments available.
![Vaccination at the forefront of the fight against hepatitis B and C | Nature Reviews Gastroenterology & Hepatology Vaccination at the forefront of the fight against hepatitis B and C | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41575-021-00570-x/MediaObjects/41575_2021_570_Fig1_HTML.png)
Vaccination at the forefront of the fight against hepatitis B and C | Nature Reviews Gastroenterology & Hepatology
![Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study - The Lancet Global Health Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study - The Lancet Global Health](https://www.thelancet.com/cms/attachment/cc9f22a8-521d-4b13-b3d1-236d5739bae5/gr1_lrg.jpg)
Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study - The Lancet Global Health
![Therapeutic vaccination for treatment of chronic hepatitis B - Cargill - 2021 - Clinical & Experimental Immunology - Wiley Online Library Therapeutic vaccination for treatment of chronic hepatitis B - Cargill - 2021 - Clinical & Experimental Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/4cb6d32c-0061-4f4b-b2de-6e5d121f0b8c/cei13614-fig-0002-m.jpg)
Therapeutic vaccination for treatment of chronic hepatitis B - Cargill - 2021 - Clinical & Experimental Immunology - Wiley Online Library
![SmartVac - Next Generation Viral Hepatitis B and C vaccine development in plantsand algae using advanced biotechnological tools - Nibio SmartVac - Next Generation Viral Hepatitis B and C vaccine development in plantsand algae using advanced biotechnological tools - Nibio](https://www.nibio.no/en/projects/smartvac-next-generation-viral-hepatitis-b-and-c-vaccine-development-in-plants-and-algae-using-advanced-biotechnological-tools/_/image/30ad6d57-5857-473c-b746-fb1fb188c0e1:e32b9e46af29f022e818cee6972b30ff695dadd2/max-1280/HCV%20talk%20Biotechnology%20Havana%202017%20Dec%206,%202017-bilde.jpg?quality=60)
SmartVac - Next Generation Viral Hepatitis B and C vaccine development in plantsand algae using advanced biotechnological tools - Nibio
Response to hepatitis B virus vaccination in individuals with chronic hepatitis C virus infection | PLOS ONE
![Viruses | Free Full-Text | Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms Viruses | Free Full-Text | Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms](https://www.mdpi.com/viruses/viruses-12-00126/article_deploy/html/images/viruses-12-00126-g001.png)
Viruses | Free Full-Text | Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms
![Evaluation of response to hepatitis B virus vaccine in adults with human immunodeficiency virus | Annals of Hepatology Evaluation of response to hepatitis B virus vaccine in adults with human immunodeficiency virus | Annals of Hepatology](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//16652681/0000001800000005/v2_201909050846/S1665268119303515/v2_201909050846/en/main.assets/gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNeKOJqKH5+Za6P+RA5Vq9DlQb8yPkJDp+N5QnnY4C2AKNE7fB9xpmj5g05vzrNkYFcjXSAMYlgZ3TxFNMvFIwtnb26G9rIMTsABjMleV/3nlC96RK2VUJQUGGmP9Qis2vFkCfiLhnZhW5qPWytyj5MDlj57hQqLFOhYDOU17MTQC69b1X/6yxh2MgX3vfQ5lGWxvzXVqaYuMcpy4pNrSTZF7n6DZDKIsjDBk91YFSjmFUv3GjHYWKsd/foR2yvMpBs=)